ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Tuesday, May 28, 2024"
Episode Synopsis
Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast The Gist Healthcare Podcast
Friday, November 7, 2025
07/11/2025
Wednesday, November 5, 2025
05/11/2025
Friday, October 31, 2025
31/10/2025
Wednesday, October 29, 2025
29/10/2025
Monday October 27, 2025
27/10/2025
Friday, October 24, 2025
24/10/2025
Wednesday, October 22, 2025
22/10/2025
Friday, October 10, 2025
10/10/2025
Wednesday, October 8, 2025
08/10/2025
In God we trust